Diego Andrés Vásquez Lesmes , Lina María Acero Ruge , Erwin Hernando Hernández Rincón , Lina Paola Avella Pérez
{"title":"Integración de las enfermedades huérfanas/raras (EHR) en los planes locales/territoriales de salud de Colombia: revisión sistemática exploratoria","authors":"Diego Andrés Vásquez Lesmes , Lina María Acero Ruge , Erwin Hernando Hernández Rincón , Lina Paola Avella Pérez","doi":"10.1016/j.rcreu.2026.504862","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Orphans/Rare diseases (ORD) in Colombia have a prevalence of 1 per 5000 persons. Globally, public policies have shown inefficacy. International efforts to raise awareness for these patients have progressed, but challenges persist in integrating them into local and territorial health plans in Colombia. Overcoming barriers in healthcare delivery and assessing the need for structural reforms are crucial.</div></div><div><h3>Objective</h3><div>To synthesize available evidence on the integration of ORD into local/territorial health plans in Colombia, providing a comprehensive view of the Colombian healthcare system in the global context.</div></div><div><h3>Methods</h3><div>An exploratory systematic review, known as a “Scoping Review,” was conducted in PubMed, Embase, Scopus, and grey literature from 2009 to 2024; 49 documents were selected for analysis.</div></div><div><h3>Results</h3><div>Of the evidence found, 20.5% (n<!--> <!-->=<!--> <!-->10) were primary studies, highlighting global public policies, and 79.5% (n<!--> <!-->=<!--> <!-->39) comprised grey literature; (n<!--> <!-->=<!--> <!-->8) discussed access barriers, health models, (n<!--> <!-->=<!--> <!-->31) addressed public policies with Colombian intervention pillars, and only (n<!--> <!-->=<!--> <!-->6) included local and territorial health plans in Colombia.</div></div><div><h3>Conclusions</h3><div>The information gathered shows that ORD pose significant challenges to healthcare systems due to their low prevalence and the lack of specific research and treatment. Despite regulatory efforts in Colombia, a comprehensive and coordinated approach is needed to effectively address these conditions.</div></div>","PeriodicalId":37643,"journal":{"name":"Revista Colombiana de Reumatologia","volume":"33 2","pages":"Article 504862"},"PeriodicalIF":0.5000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Colombiana de Reumatologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0121812326000010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Orphans/Rare diseases (ORD) in Colombia have a prevalence of 1 per 5000 persons. Globally, public policies have shown inefficacy. International efforts to raise awareness for these patients have progressed, but challenges persist in integrating them into local and territorial health plans in Colombia. Overcoming barriers in healthcare delivery and assessing the need for structural reforms are crucial.
Objective
To synthesize available evidence on the integration of ORD into local/territorial health plans in Colombia, providing a comprehensive view of the Colombian healthcare system in the global context.
Methods
An exploratory systematic review, known as a “Scoping Review,” was conducted in PubMed, Embase, Scopus, and grey literature from 2009 to 2024; 49 documents were selected for analysis.
Results
Of the evidence found, 20.5% (n = 10) were primary studies, highlighting global public policies, and 79.5% (n = 39) comprised grey literature; (n = 8) discussed access barriers, health models, (n = 31) addressed public policies with Colombian intervention pillars, and only (n = 6) included local and territorial health plans in Colombia.
Conclusions
The information gathered shows that ORD pose significant challenges to healthcare systems due to their low prevalence and the lack of specific research and treatment. Despite regulatory efforts in Colombia, a comprehensive and coordinated approach is needed to effectively address these conditions.
期刊介绍:
The Colombian Journal of Rheumatology (Revista Colombiana de Reumatología) is the official organ of the Colombian Association of Rheumatology (Asociación Colombiana de Reumatología) and the Central American, Caribbean and Andean Association of Rheumatology (Asociación Centroamericana Caribe Andina de Reumatología) - ACCA. It was created in December 1993 with the purpose of disseminating scientific information derived from primary and secondary research and presenting cases coming from the practice of Rheumatology in Latin America. Since its foundation, the Journal has been characterized by its plurality with subjects of all rheumatic and osteomuscular pathologies, in the form of original articles, historical articles, economic evaluations, and articles of reflection and education in Medicine. It covers an extensive area of topics ranging from the broad spectrum of the clinical aspects of rheumatology and related areas in autoimmunity (both in pediatric and adult pathologies), to aspects of basic sciences. It is an academic tool for the different members of the academic and scientific community at their different levels of training, from undergraduate to post-doctoral degrees, managing to integrate all actors inter and trans disciplinarily. It is intended for rheumatologists, general internists, specialists in related areas, and general practitioners in the country and abroad. It has become an important space in the work of all rheumatologists from Central and South America.